124I-labeled monoclonal antibody Mu 11-1F4
2625A
Phase 1 mab completed
Quick answer
124I-labeled monoclonal antibody Mu 11-1F4 for AL Amyloidosis is a Phase 1 program (mab) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BRIGHT MINDS BIOSCIENCES INC.
- Indication
- AL Amyloidosis
- Phase
- Phase 1
- Modality
- mab
- Status
- completed